Efficacy and hypoglycemia-related safety of henagliflozin or dapagliflozin as add-on to CSII in hospitalized patients with T2DM: A retrospective matched study using continuous glucose monitoring
用户k7g3AjDeE8DM
1个月前
90
10
已完结
1. 系统已在2026-04-15 10:22:38对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jdiacomp.2026.109315
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1056872726000607
其他信息:
出版社: Elsevier BV
作者: Heng Tang; Zhifeng Chen; Juan Wang; Huanhuan Meng; Wen Zhang

